Rankings
▼
Calendar
AMPH Q4 2016 Earnings — Amphastar Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
AMPH
Amphastar Pharmaceuticals, Inc.
$860M
Q4 2016 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$64M
Gross Profit
$20M
31.4% margin
Operating Income
-$5M
-7.1% margin
Net Income
-$3M
-4.3% margin
EPS (Diluted)
$-0.06
QoQ Revenue Growth
-1.1%
Cash Flow
Operating Cash Flow
$14M
Free Cash Flow
$9M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$428M
Total Liabilities
$98M
Stockholders' Equity
$329M
Cash & Equivalents
$72M
Revenue Segments
Active Pharmaceutical Ingredient Segment
$5M
100%
Geographic Segments
U
$60M
100%
← FY 2016
All Quarters
Q1 2017 →
